| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.59B | 19.93B | 20.43B | 19.75B | 18.57B | 14.15B |
| Gross Profit | 12.42B | 12.08B | 12.01B | 11.60B | 10.91B | 7.67B |
| EBITDA | 512.03M | 667.89M | 827.41M | 1.07B | 1.02B | -1.32B |
| Net Income | -275.70M | -96.94M | 629.27M | 597.26M | 617.05M | -2.45B |
Balance Sheet | ||||||
| Total Assets | 19.78B | 20.00B | 20.11B | 19.14B | 18.25B | 17.85B |
| Cash, Cash Equivalents and Short-Term Investments | 4.63B | 4.77B | 4.99B | 4.49B | 4.68B | 4.57B |
| Total Debt | 5.95B | 6.01B | 5.77B | 5.60B | 5.44B | 6.71B |
| Total Liabilities | 16.00B | 15.62B | 15.58B | 15.14B | 14.85B | 14.43B |
| Stockholders Equity | 3.79B | 4.38B | 4.53B | 3.99B | 3.40B | 3.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -277.32M | 185.96M | -73.33M | 1.48B | -1.02B |
| Operating Cash Flow | 0.00 | 548.95M | 699.10M | 1.06B | 1.73B | -717.84M |
| Investing Cash Flow | 0.00 | -1.09B | -687.76M | -1.49B | -316.82M | -369.75M |
| Financing Cash Flow | 0.00 | 89.01M | 50.32M | 10.64M | -1.33B | 1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥2.05B | 1.76 | ― | 3.76% | -2.06% | -109.18% | |
58 Neutral | ¥1.62B | 12.62 | ― | 2.62% | 11.55% | 28.89% | |
57 Neutral | ¥1.92B | 1.82 | ― | ― | 8.17% | 37.03% | |
52 Neutral | ¥10.32B | 5.24 | ― | 5.06% | 0.36% | 81.58% | |
41 Neutral | ¥2.25B | 11.92 | ― | ― | -6.45% | 99.39% | |
40 Underperform | ¥5.03B | 8.38 | ― | ― | 12.42% | 4.67% |